为您找到"
hy+10182
"相关结果约100,000,000个
HY-10182 related products. MedChemExpress (MCE) provides thousands of inhibitors, modulators and agonists with high purity and quality, excellent customer reviews, precise and professional product citations, tech support and prompt delivery.
Medchemexpress, HY-10182 100mg CHIR-99021 CT99021 CAS:252917-06-9 Formula:C22H18Cl2N8 IC50: 10 nM/6.7 nM (GSK-3α/β) Purity:98% CHIR-99021 is a GSK-3α/β inhibitor with IC 50 of 10 nM/6.7 nM; > 500-fold selectivity for GSK-3 versus its closest homologs CDC2 and ERK2, as well as other protein kinases. Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and ...
Laduviglusib CHIR-99021 | HY-10182 Laduviglusib (CHIR-99021) is a potent and selective GSK-3α/β inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib is also a potent Wnt/β-catenin signaling pathway activator.
HY-10182 is a laboratory instrument designed for cell culture and analysis. It provides precise temperature and environmental control for maintaining optimal conditions for cell growth and experimentation.
Laduviglusib [252917-06-9], purity 99.76, MW 465.34, formula C22H18Cl2N8. Available from MedChem Express at Bio-Connect—fast, reliable Benelux delivery.
HY-10182-5mg | Laduviglusib [252917-06-9]. Antibodies, Recombinant proteins, ELISA kits, RNAi, cDNA clones, Antibody Array, Luminex kits. Reagents and instruments for immunology...
> selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib is also a potent Wnt/β-catenin signaling pathway activator. Laduviglusib enhances mouse and human embryonic stem cells self-renewal. Laduviglusib
REFERENCES [1]. Ring DB, et al. Selective glycogen synthase kinase 3 inhibitors potentiate activation of glucose transport and utilization in vitro and in vivo. Diabetes. 2003 Mar;52(3):588-
Laduviglusib (CHIR-99021) (GMP) is Laduviglusib (HY-10182) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Laduviglusib is a potent, orally active and selective GSK-3α/β inhibitor. - Mechanism of Action & Protocol.
HY-10182 50mg Laduviglusib CAS: 252917-06-9 Laduviglusib (CHIR-99021) is a potent and selective GSK-3α/β inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib is also a potent Wnt/β-catenin signaling pathway activator. Laduviglusib enhances mouse and human embryonic stem cells self-renewal ...